Corticosteroid News and Research

RSS
Corticosteroids are any steroid hormones made in the adrenal cortex (the outer part of the adrenal gland). They are also made in the laboratory. Corticosteroids have many different effects in the body, and are used to treat many different conditions. They may be used as hormone replacement, to suppress the immune system, and to treat some side effects of cancer and its treatment. Corticosteroids are also used to treat certain lymphomas and lymphoid leukemias.
AGA's new clinical guideline to help manage patients with mild-to-moderate ulcerative colitis

AGA's new clinical guideline to help manage patients with mild-to-moderate ulcerative colitis

Potential combination therapy against rare disease of the bone marrow could improve treatment

Potential combination therapy against rare disease of the bone marrow could improve treatment

Pooled analysis of Intersect ENT's steroid releasing implants in patients after frontal sinus surgery to be published

Pooled analysis of Intersect ENT's steroid releasing implants in patients after frontal sinus surgery to be published

How to avoid shoulder injury related to vaccine administration

How to avoid shoulder injury related to vaccine administration

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Disruption in combination inhaled corticosteroid therapy may impact patients' symptoms and disease control

Disruption in combination inhaled corticosteroid therapy may impact patients' symptoms and disease control

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

Study reveals promising new drug candidate to treat acute renal failure

Study reveals promising new drug candidate to treat acute renal failure

FDA approves Teva’s AJOVY injection for preventive treatment of migraine in adults

FDA approves Teva’s AJOVY injection for preventive treatment of migraine in adults

Inhaled steroid use linked to greater risk of NTM lung infections

Inhaled steroid use linked to greater risk of NTM lung infections

FDA approves new treatment for people with hairy cell leukemia

FDA approves new treatment for people with hairy cell leukemia

Researchers develop new wearable photostimulator that speeds up hair growth

Researchers develop new wearable photostimulator that speeds up hair growth

Pfizer terminates clinical studies evaluating domagrozumab for treatment of Duchenne muscular dystrophy

Pfizer terminates clinical studies evaluating domagrozumab for treatment of Duchenne muscular dystrophy

EC grants marketing authorization for ONPATTRO (patisiran) in Europe

EC grants marketing authorization for ONPATTRO (patisiran) in Europe